History

2016
  • 01

    Osong Medical Innovation Foundation: Creation Value for Promotion of R&D

  • 01

    Osong Medical Innovation Foundation: Creation Value for Product and Process Development of Clinical Specimens Grant selection

  • 04

    Ministry of Trade, Industry and Energy: International Cooperative Technology Development Grant application

  • 04

    CEO Visit to government agencies in the Nanjing, Yangzhou, and Ningbo cities of China with plans to establish a joint venture company

2015
  • 03

    R&D institute establishment and KOITA accreditation

  • 04

    Venture Business certification by the Korea Venture Capital Association

  • 04

    2015 BioKorea (Seoul, Korea) exhibitioner

  • 05

    Ministry of Trade, Industry and Energy: Focus on Fostering Regional Business R&D Grant selection

  • 06

    Chinese Biopharmaceutical Association 2016 Annual Conference (Lianyungang, China) participant

  • 06

    Small and Medium Business Administration: Establishment of Business Growth Grant selection

  • 08

    Chungbuk Industry University Cooperation Institute: R&D Grant selection

  • 08

    Ministry of Trade, Industry, and Energy: Global Technology Consulting Grant selection

  • 10

    Korea Institute of Startup and Entrepreneurship Development: Establishment Business Customization Grant selection

  • 10

    2015 BioEurope (Munich, Germany) exhibitioner

  • 11

    Ministry of Trade, Industry and Energy: Promotion of Province non-R&D Grant selection

  • 12

    KASBP-DC’s 2015 US Cooperative Conference for Life Science Industry (KUCCLSI) participant

2014
  • 04

    Headquarters move into Osong Biovalley’s Venture Research Center I

  • 11

    Chungbuk Industry University Cooperation Institute: R&D Grant selection

2013
  • 03

    2013 BioPharma Asia Convention CEO lecture

  • 11

    “Rophibio, Inc.” established in Osong, Korea

2012
  • 12

    CEO article published in the New York Health Forum magazine

2011
  • 04

    Contract between the Chungbuk governor and Osong Biovalley

  • 05

    Contractual agreement with CMO Goodwin Biotechnology Inc., Florida USA

2010
  • 10

    2010 Mid-Atlantic BIO Conference CEO lecture

  • 11

    U.S. Federal Government: Qualifying Therapeutic Discovery Project (QTDP) Grant selection

2009
  • 03

    KOTRA/Invest Korea’s 2009 Spring Korea Foreign Investment Forum participant

  • 04

    Received 2009 Maryland Incubator Company of the Year Award

  • 06

    KOTRA’s 2009 Global BioTech Forum participant

  • 09

    Montgomery County Technology Growth Program selection

  • 10

    Introduced in the Maryland Gazette’s published newspaper article “County’s incubators hatch business success stories”

2008
  • 04

    Selected as Montgomery County’s “Outstanding Company”

  • 06

    13th Chinese Biopharmaceutical Association & Shanghai International Forum on Biotechnology and Pharmaceutical Industry participant

  • 07

    Maryland Industrial Partnerships Grant selection

  • 10

    Montgomery County’s Business Mission Trip in Korea and China participant

  • 10

    Maryland Export MD Grant selection

  • 12

    Maryland Technology Transfer Fund selection

2007
  • 11

    Established in Maryland, USA